RxDoctor Payments Data

Andrea Perry

Family · Eaton Rapids, MINPI 1407312200

Payments from drug & device makers

$964in general payments, 2019–2025

Across 46 payments — averaging $20.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$185
  • AbbVie$111
  • AstraZeneca$80
  • Medtronic$62
  • GSK$61
  • Otsuka America Pharmaceutical, Inc.$43
  • plus $422 from 19 others

What the payments were for

  • Food & beverage$964100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$964 in reported general payments places this provider in the 70th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,297
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen54$765
Albuterol Sulfate HfaAlbuterol Sulfate26$534
Levothyroxine Sodium15$496
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav63$443
Gabapentin31$347
Prednisone103$303
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst26$242
Etodolac25$238
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$230
Doxycycline Monohydrate28$218
Omeprazole18$198
Atorvastatin Calcium20$175
Cephalexin51$170
Trazodone Hcl14$144

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$61$8,29713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,657 family providers in Michigan.

Other family in Eaton Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →